Sat, June 14, 2025
Fri, June 13, 2025
Thu, June 12, 2025
Wed, June 11, 2025
Tue, June 10, 2025
Mon, June 9, 2025
Sun, June 8, 2025
Sat, June 7, 2025
Fri, June 6, 2025
Thu, June 5, 2025
Wed, June 4, 2025
Tue, June 3, 2025
Mon, June 2, 2025
Sun, June 1, 2025
Sat, May 31, 2025
Fri, May 30, 2025
Thu, May 29, 2025
Wed, May 28, 2025
Tue, May 27, 2025
Mon, May 26, 2025
Sun, May 25, 2025
Sat, May 24, 2025
Fri, May 23, 2025
Thu, May 22, 2025
Wed, May 21, 2025
Tue, May 20, 2025
[ Tue, May 20th ] - 13abc
Moment of Science: Cicadas
Mon, May 19, 2025
Sun, May 18, 2025
Sat, May 17, 2025
Fri, May 16, 2025
Thu, May 15, 2025
Wed, May 14, 2025
Tue, May 13, 2025

CRISPR pioneer Prime Medicine switches CEO and lays off quarter of its staff


//science-technology.news-articles.net/content/2 .. tches-ceo-and-lays-off-quarter-of-its-staff.html
Published in Science and Technology on by STAT   Print publication without navigation

Prime Medicine, known for its goal of treating hundreds of diseases with CRISPR, says it's narrowing its focus to two. It also announced big layoffs and a new CEO.

Prime Medicine, a biotech company focused on gene editing, announced on May 19, 2025, that it is laying off 20% of its workforce and that its CEO, Keith Gottesdiener, will step down. The layoffs are part of a strategic restructuring to extend the company's cash runway and prioritize its most promising programs. Gottesdiener, who has led the company since its inception in 2020, will be replaced by the company's chief scientific officer, David Liu, on an interim basis while a search for a permanent CEO is conducted. The company's lead program, PM359, which targets chronic granulomatous disease, remains on track for an investigational new drug application filing in the second half of 2025.

Read the Full STAT Article at:
[ https://www.statnews.com/2025/05/19/gene-editing-biotech-company-prime-medicine-announces-layoffs-ceo-departure/ ]

Publication Contributing Sources